AzTrials
AzTrials

Childhood ObesityPhase 2NCT01705093

The Effects of California Strawberries on Parameters of Cardiovascular Health

A Phase 2 study testing flavonoid-rich freeze-dried strawberry powder in people with Childhood Obesity and Cardiovascular Disease, run by University of California, Davis at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The prevalence of childhood obesity has been increasing over the past couple of decades. Similar to adults, overweight and obesity in young children and adolescents is associated with an increased number of cardiovascular risk factors including dyslipidemia, hypertension, insulin resistance and Type 2 diabetes. Read more about this study

Who is it for?
Ages 14 to 18 years, men onlyHealthy volunteers can take part
Conditions the study is for
Childhood Obesity, Cardiovascular Disease
What is being tested?
flavonoid-rich freeze-dried strawberry powder
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
32 participants
Where
1 siteUnited States
Study dates
May 2012to Jan 2015
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 to 18 years
  • Men only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Male subjects, age 14 - 18 years.
  • BMI for age and gender >75th percentile (based on CDC growth charts)
  • Subject is willing and able to comply with the study protocols.

Who cannot join

  • Inability to wear PAT probes
  • Inability to remain still and remain quiet during test procedures
  • BMI for age and gender ≤ 75th percentile (based on CDC growth charts)
  • The use of medications that affect vascular function
  • Regular use of dietary supplements during the last 6 months
  • Blood pressure for age, gender and height ≥95th percentile
Show all 17Show fewer
  • Chronic/routine high intensity exercise or current participation in a sports program
  • Self/Parent reported use of anticoagulation agents including NSAIDs
  • Self/Parent reported use of oral cortisone or other immunosuppressive agents,
  • Self/Parent reported underlying neoplasia or immunological disease
  • Self/Parent reported diabetes
  • Food faddists or those taking a non-traditional diet
  • Allergies to fruit
  • Abnormal Liver, CBC or Chemistry panels (laboratory values outside the reference
  • range) if determined to be clinically significant by the study physician.
  • Self/Parent reported malabsorption (e.g. difficulty digesting or absorbing nutrients from food, potentially leading to bloating, cramping or gas).
  • Asthma (can be worsened by mild to moderate food allergies).

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Ragle Human Nutrition Research Center, Academic Surge, UC Davis

    Davis, California, 95616

Other trials in United States

About this study

The prevalence of childhood obesity has been increasing over the past couple of decades. Similar to adults, overweight and obesity in young children and adolescents is associated with an increased number of cardiovascular risk factors including dyslipidemia, hypertension, insulin resistance and Type 2 diabetes. Epidemiological and clinical studies suggest that foods and ingredients rich in select flavonoids, such as cocoa, red grape products, tea, citrus fruits, and strawberries are protective against the development of cardiovascular disease. Strawberries are rich in flavonoids, particularly anthocyanins, flavanols, flavonols, ellagic acid and its glucose ester, ellagitanin. A number of in vitro studies have observed that these isolated compounds, as well as strawberry extracts have the potential to affect outcomes of cardiovascular health, including vascular reactivity, cellular signaling and oxidant defense6,7. We hypothesize that strawberry intake will lead to improvements in select measures of cardiovascular function in overweight and obese adolescent males.

Being tested
flavonoid-rich freeze-dried strawberry powder, macronutrient-matched control powder
Keywords
strawberry, cardiovascular, obesity, adolescent
Medical subject headings
Pediatric Obesity, Cardiovascular Diseases, Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • flavonoid-rich freeze-dried strawberry powderDietary supplement

    50g of flavonoid-rich freeze-dried strawberry powder

  • macronutrient-matched control powderDietary supplement

    50g macronutrient-matched powder that will lack strawberry flavonoids

Study groups in NCT01705093
Study groupRoleWhat they receive
Flavonoid-rich freeze-dried strawberry powderExperimental50g of flavonoid-rich freeze-dried strawberry powder
Receives: Dietary Supplement: flavonoid-rich freeze-dried strawberry powder
macronutrient- matched control powderPlacebo comparator50g macronutrient-matched control powder that will lack strawberry flavonoids
Receives: Dietary Supplement: macronutrient-matched control powder

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Vascular function measured by peripheral arterial tonometry

    Change from baseline at 1 hour and 1 week post consumption of freeze-dried strawberry powder or control powder

    Measured: Change from baseline in vascular function at 1 hour and 1 week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Oct 2012 (estimated)
  2. Study startMay 2012
  3. Primary completionJan 2015
  4. Study completionJan 2015

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01705093
Sponsor's protocol ID
333071
Status last verified
Jul 2017
First submitted
31 Aug 2012
Last updated
14 Jul 2017
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing flavonoid-rich freeze-dried strawberry powder in people with Childhood Obesity and Cardiovascular Disease, run by University of California, Davis at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Vascular function measured by peripheral arterial tonometry (time frame: Change from baseline in vascular function at 1 hour and 1 week). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in